In a new study, Gauthier was surgically implanted with an experimental spinal cord neuroprosthesis to correct walking disorders in people with Parkinson’s disease.
Marc Gauthier, 63, who has Parkinson's disease, was treated with a spinal cord neuroprosthesis for his locomotor symptoms.
Then, Gauthier was invited to participate in the new study to test the experimental spinal cord neuroprosthesis.
Next, they implanted an array of electrodes against the lower region of Gauthier’s spinal cord to target those zones.
“With this spinal cord stimulation, we still have an effect, but we have to fight against worse and more severe symptoms,” Bloch said.
Persons:
Marc Gauthier, Gauthier, ” Gauthier, Dr, Eduardo Moraud, ” Moraud, Gilles Weber, CHUV Gauthier, Jocelyn Bloch, ” Bloch, ”, Svjetlana, Miocinovic, David Dexter, Parkinson’s, Dexter, Sanjay Gupta, Moraud, Michael J, Bloch, Grégoire, ” Courtine, “
Organizations:
CNN, Nature, Lausanne University Hospital, Emory University School of Medicine, Parkinson’s, Science Media, DBS, CNN Health, Fox Foundation, Medical
Locations:
Bordeaux, France, Switzerland, Netherlands